Safety of long-term monthly cycles of methylprednisolone in combination with interferon β-1a im in treatment-naïve early relapsing-remitting multiple sclerosis patients in the MECOMBIN trial

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2009
This article has no abstract
Epistemonikos ID: b8df9eafe2126d6bd82f9b977a034fcee94514e0
First added on: Apr 30, 2026